Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04341246 · ClinicalTrials.gov registry record
Characterization and Technical Evaluation of cT1 for NASH (CATE-NASH)
A clinical trial, sponsored by Perspectum.
- Completed
- Registry status
- 28
- Enrollment target
NCT04341246 is a clinical trial that has completed, run by Perspectum. The registered enrollment target is 28 participants.
The verdict
NCT04341246 has completed, sponsored by Perspectum.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate to provide evidence to establish tightly defined cut-offs to identify patients for NASH clinical trial inclusion using cT1 and/or PDFF. The study will be divided into 2 sub groups comprising of cases and controls.
Interventions
- DEVICE LiverMultiscan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2021-01-28 |
| Est. Completion | 2023-06-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04341246
The ClinicalTrials.gov registry entry for NCT04341246 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Perspectum, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LiverMultiscan is the first listed.
NCT04341246 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04341246 about?
NCT04341246 is a clinical study titled "Characterization and Technical Evaluation of cT1 for NASH (CATE-NASH)". The primary objective of this study is to evaluate to provide evidence to establish tightly defined cut-offs to identify patients for NASH clinical trial inclusion using cT1 and/or PDFF. The study will be divided into 2 sub groups comprising of cases and controls.
What is the current status of trial NCT04341246?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2021-01-28. Estimated completion is 2023-06-12.
What interventions are being tested in trial NCT04341246?
The interventions under investigation include: LiverMultiscan (DEVICE).
Who is sponsoring clinical trial NCT04341246?
This trial is sponsored by Perspectum, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.